Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
- 1 May 1994
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 343 (8907), 1177-1183
- https://doi.org/10.1016/s0140-6736(94)92398-1
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma CellsJNCI Journal of the National Cancer Institute, 1993
- Micrometastatic tumour cells in bone marrow in colorectal cancerThe Lancet, 1993
- Current applications of monoclonal antibodies for the therapy of hematopoietic cancersCurrent Opinion in Immunology, 1991
- Tumour-growth suppression in nude mice by a murine monoclonal antibody: Factors hampering successful therapyInternational Journal of Cancer, 1991
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI Journal of the National Cancer Institute, 1988
- Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets.The Journal of Experimental Medicine, 1988
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- The randomization and stratification of patients to clinical trialsJournal of Chronic Diseases, 1974